|  | N = 42 |
---|---|---|
Median dose prescribed to the whole pelvis (Gy) |  | 30.6 (range, 26–50.4) |
Median brachytherapy fractions (n) |  | 4 (range, 2–5) |
Median volume of HR-CTV at initial HBT (ml) |  | 37.1 (range, 12.1–89.2) |
Median HR-CTV D90 in EQD2 (Gy) |  | 70.3 (range, 56.2–97.3) |
Median HR-CTV V100 (%) |  | 95.9 (range, 79.3–100) |
Median HR-CTV V150 (%) |  | 57.7 (range, 39.1–89.4) |
Median HR-CTV V200 (%) |  | 29.9 (range, 19.6–58.5) |
Median dose of bladder D2cc in EQD2 (Gy) |  | 72.4 (range, 60.7–87.2) |
Median dose of rectum D2cc in EQD2 (Gy) |  | 64.5 (range, 47.6–75.2) |
Concurrent chemotherapy | Yes | 28 |
No | 14 |